Computation screening and molecular docking of FDA approved viral protease inhibitors as a potential drug against COVID-19

AIM: This study demonstrated potent inhibitors against COVID-19 using the molecular docking approach of FDA approved viral antiprotease drugs. BACKGROUND: COVID-19 has now spread throughout world. There is a serious need to find potential therapeutic agents. The 3C-like protease (Mpro/6LU7) is an at...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Gastroenterol Hepatol Bed Bench
Główni autorzy: Absalan, Abdorrahim, Doroud, Delaram, Salehi-Vaziri, Mostafa, Kaghazian, Hooman, Ahmadi, Nayebali, Zali, Fatemeh, Pouriavali's, Mohamamd Hassan, Mousavi-Nasab, Seyed Dawood
Format: Artigo
Język:Inglês
Wydane: Shaheed Beheshti University of Medical Sciences 2020
Hasła przedmiotowe:
Original Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7682959/
https://ncbi.nlm.nih.gov/pubmed/33244378
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy